Isentress 400 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJH0V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,834
Award facts
- Contract value 100% obligated
- $15,833.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 10, 2026, the Defense Logistics Agency awarded a delivery order valued at $15,833.71 to AmerisourceBergen Drug Corp for the supply of Isentress 400 mg tablets (60-count units). The contract carries a firm fixed-price structure with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is executed under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031, which serves as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare programs globally.
The supply of Isentress, an antiretroviral medication used in HIV treatment, supports the Defense Logistics Agency's pharmaceutical supply chain operations serving military treatment facilities and veteran healthcare programs. This delivery order exemplifies the routine fulfillment of specialty pharmaceutical requirements through Cencora's comprehensive IDC vehicle, which encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The award is scheduled for completion by January 12, 2026, reflecting the time-sensitive nature of pharmaceutical procurement for federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FJH0V?
SPE2DR26FJH0V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 10, 2026.
How much is contract SPE2DR26FJH0V worth?
The government has obligated $15,834 on SPE2DR26FJH0V.
Is contract SPE2DR26FJH0V an order under another contract?
Yes. SPE2DR26FJH0V is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH0V competed?
The extent of competition for SPE2DR26FJH0V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award